Deep Molecular Remission Predicts Better Clinical Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) Treated with Obecabtagene Autoleucel (obe-cel)
Jabbour E. Park J. Shaughnessy P. Logan A. Sandhu K. Abedi M. Shah B. Bishop M. DeAngelo D. Lao-Sirieix P. Brugger W. Zhang Y. Roddie C (2025). Deep Molecular Remission Predicts Better Clinical Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) Treated with Obecabtagene Autoleucel (obe-cel). Transplantation and Cellular Therapy, 31(2), S216-S217. https://doi.org/10.1016/j.jtct.2025.01.332
- Authors
- Elias Jabbour, Jae H Park, Paul Shaughnessy, Aaron C Logan, Karamjeet S Sandhu, Mehrdad Abedi, Bijal D Shah, Michael R Bishop, Daniel J DeAngelo, Pierre Lao-Sirieix, Wolfram Brugger, Yiyun Zhang, Claire Roddie
- Journal
- Transplantation and Cellular Therapy
- First published
- 2025
- Number of citations
- 1
- Type
- Journal Article